aana glp-1 guidelines RA guidance roundup Holding GLP-1 Agonists Prior to

Conclusion The cardioprotective effects and low risk of hypoglycemia of GLP-1 RAs make them preferred agents in any multidisciplinary approach aiming to reduce CV disease burden and improve prognosis

Self-monitoring of blood glucose (SMBG) offers real-time feedback and helps identify patterns in glycaemic response

Efficacy of oncedaily oral orforglipron in adults with obesity (ATTAIN1)

Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, though these medications are often collectively referred to as incretin-based therapies

Physiologic stress follicles shift into shedding Low protein intake ( 70 ng/mL Low levels of Vitamin D, B12, and Folate slow follicle activity Zinc and Copper impact Keratin infrastructure Thyroid shifts cause shedding CBC, CMP protein or nutrient imbalances Nutrition and Hair Health During GLP-1 Medication Hair needs protein, minerals, and collagen to stay in active growth mode

Navigating these medications can feel complex